KFDA lifts ban on Novartis flu vaccine

The Korea Food and Drug Administration announced Monday it has lifted a ban on import of Agrippal junior prefilled syringe, an influenza vaccine made by Swiss pharmaceutical giant Novartis after documenting that concerns over impurities were unfounded.

"We lifts the suspension of import and use of Novartis flu vaccines since the company has managed to document the quality of the batches that...